Frösner G G, Brodersen M, Papaevangelou G, Sugg U, Haas H, Mushahwar I K, Ling C M, Overby L R, Deinhardt F
J Med Virol. 1978;3(1):67-76. doi: 10.1002/jmv.1890030114.
A solid-phase radioimmunoassay using anti-HBe-coated polysterence beads and iodine-125-labeled anti-HBe of human origin was developed for the detection of HBeAg. Anti-HBe could be determined by a blocking test. Both assays were about 500-fold more sensitive than immunodiffusion. Few nonspecific positive results for HBeAg could be recognized in the anti-HBe test by increase in cpm over that of the negative control. HBeAg was not found in acute hepatitis A and non A-non B hepatitis or in a control group of accident patients. On admission to the hospital 12 of 48 (25%) acute hepatitis B patients from Greece and 17 of 20 (85%) acute hepatitis B patients from Germany were HBeAg-positive. All 39 initially HBeAg negative sera were already anti-HBe positive. Tests of the acute stage and follow-up sera of the 20 German patients indicated that HBeAg is regularly present in the incubation period and early acute phase of hepatitis B. After onset of disease the antigen is cleared from the serum very rapidly in uncomplicated cases and is usually followed by the appearance of anti-HBe. Like anti-HBc, anti-HBe can serve as a tool for the diagnosis of hepatitis B after the disappearance of HBsAg.
我们开发了一种固相放射免疫分析法,用于检测HBeAg,该方法使用包被有抗HBe的聚苯乙烯珠和人源碘-125标记的抗HBe。抗HBe可通过阻断试验来测定。这两种检测方法的灵敏度均比免疫扩散法高约500倍。在抗HBe检测中,通过计数每分钟脉冲数(cpm)高于阴性对照来识别少数HBeAg非特异性阳性结果。在甲型急性肝炎和非甲非乙型肝炎患者或事故患者对照组中未发现HBeAg。希腊的48例急性乙型肝炎患者中有12例(25%)入院时HBeAg呈阳性,德国的20例急性乙型肝炎患者中有17例(85%)入院时HBeAg呈阳性。所有39份最初HBeAg阴性的血清已呈抗HBe阳性。对20例德国患者急性期和随访血清的检测表明,HBeAg在乙型肝炎潜伏期和急性期早期经常出现。发病后,在无并发症的情况下,抗原很快从血清中清除,随后通常会出现抗HBe。与抗HBc一样,抗HBe可作为HBsAg消失后诊断乙型肝炎的一种手段。